Assessment of retinal manifestations of Parkinson's disease using spectral domain optical coherence tomography: A study in Indian eyes

被引:3
作者
Verghese, Shishir [1 ]
Berkowitz, Sean T. [4 ]
Shah, Virna M. [2 ]
Shah, Parag [1 ]
Priya, S. [2 ]
Saravanan, Veerappan R. [1 ]
Narendran, Venkatapathy [1 ]
Selvan, V. A. [3 ]
机构
[1] Aravind Eye Hosp & Postgrad Inst Ophthalmol, Dept Retina & Vitreous, Coimbatore, Tamil Nadu, India
[2] Aravind Eye Hosp & Postgrad Inst Ophthalmol, Dept Neuro Ophthalmol, Coimbatore, Tamil Nadu, India
[3] Kovai Med Coll Hosp, Dept Neurol, Coimbatore, Tamil Nadu, India
[4] Vanderbilt Univ, Dept Ophthalmol, Sch Med, Nashville, TN USA
关键词
Ganglion cell layer; Parkinson's disease; retinal nerve fiber layer; SD-OCT; ALPHA-SYNUCLEIN; DYSFUNCTION; SEVERITY;
D O I
10.4103/ijo.IJO_1409_21
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To assess the retinal manifestations of Parkinson's disease using optical coherence tomography. Methods: A prospective case-control study comparing 30 eyes from 15 patients with Parkinson's disease and 22 eyes from 11 healthy age-matched controls. Total macular subfield thickness and the thickness of the ganglion cell layer, nerve fiber layer, and peripapillary retinal nerve fiber layer were measured with spectral-domain optical coherence tomography (SD-OCT). Results: The mean age of PD patients was 68.4 years +/- 10.64 (range: 46-82) and in the control group was 66.36 +/- 5.22 (range: 64-68). The average disease duration in patients with PD was 6.7 +/- 2.8 years (range: 2-10 years). The mean best-corrected visual acuity in PD was 20/26 and 20/20 in controls, with P = 0.0059, which was significant. Significant difference was also found in the contrast sensitivity between both groups. Structural differences in the central macular thickness (P = 0.0001), subfield thicknesses in the superior (P = 0.003), inferior (P = 0.001), nasal (P = 0.004), and temporal subfields (P = 0.017) was seen. Severe thinning of the ganglion cell layer was seen in PD patients (P = 0.000) as well as of the nerve fiber layer (P = 0.004). Peripapillary retinal nerve fiber thickness measured showed significant thinning in superotemporal (P = 0.000), superonasal (P = 0.04), inferonasal (P = 0.000), inferotemporal (P = 0.000), nasal (P = 0.000), and temporal quadrants (P = 0.000). Conclusion: Visual dysfunction was observed in patients with PD along with structural alterations on OCT, which included macular volumes, ganglion cell layer, and peripapillary retinal nerve fiber layer.
引用
收藏
页码:448 / 452
页数:5
相关论文
共 50 条
  • [1] Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease
    Uchida, Atsuro
    Pillai, Jagan A.
    Bermel, Robert
    Bonner-Jackson, Aaron
    Rae-Grant, Alexander
    Fernandez, Hubert
    Bena, James
    Jones, Stephen E.
    Leverenz, James B.
    Srivastava, Sunil K.
    Ehlers, Justis P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (07) : 2768 - 2777
  • [2] Evaluation of Choroidal and Retinal Thickness Changes in Parkinson's Disease Using Spectral Domain Optical Coherence Tomography
    Moschos, Marilita M.
    Chatziralli, Irini P.
    SEMINARS IN OPHTHALMOLOGY, 2018, 33 (04) : 494 - 497
  • [3] Retinal pigment epithelial changes in Parkinson's disease: A spectral domain optical coherence tomography study
    Gunay, Betul Onal
    Usta, Nuray Can
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2023, 41
  • [4] Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies
    Chrysou, Asterios
    Jansonius, Nomdo M.
    van Laar, Teus
    PARKINSONISM & RELATED DISORDERS, 2019, 64 : 40 - 49
  • [5] Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
    Aaker, Grant D.
    Myung, Jane S.
    Ehrlich, Joshua R.
    Mohammed, Mujtaba
    Henchcliffe, Claire
    Kiss, Szilard
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 1427 - 1432
  • [6] Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease
    Stemplewitz, Birthe
    Keserue, Matthias
    Bittersohl, Diana
    Buhmann, Carsten
    Skevas, Christos
    Richard, Gisbert
    Hassenstein, Andrea
    ACTA OPHTHALMOLOGICA, 2015, 93 (08) : E672 - E677
  • [7] Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease
    Mailankody, Pooja
    Battu, Rajani
    Khanna, Anjani
    Lenka, Abhishek
    Yadav, Ravi
    Pal, Pramod Kumar
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (10) : 1164 - 1169
  • [8] Retinal capillary plexus in Parkinson's disease using optical coherence tomography angiography
    Giachos, Ioannis
    Doumazos, Spyridon
    Tsiogka, Anastasia
    Manoli, Konstantina
    Tagaris, George
    Rotsos, Tryfon
    Kozobolis, Vassilios
    Iliopoulos, Ioannis
    Moschos, Marilita
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (01) : 131 - 136
  • [9] Optical coherence tomography in patients with Parkinson's disease
    El-Kattan, Manal Mahmoud
    Esmat, Soheir Mohammed
    Esmail, Eman Hasan
    Deraz, Heba Assem
    Ismail, Rania Shehata
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2022, 58 (01)
  • [10] A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography
    Slotnick, Samantha
    Ding, Yin
    Glazman, Sofya
    Durbin, Mary
    Miri, Shahnaz
    Selesnick, Ivan
    Sherman, Jerome
    Bodis-Wollner, Ivan
    MOVEMENT DISORDERS, 2015, 30 (12) : 1692 - 1695